Answer
Tucatinib may harm the pregnant woman and/or foetus/newborn based on animal findings, with no human pregnancy data and animal evidence of reproductive toxicity, so Tukysa should not be used during pregnancy unless the woman's clinical condition requires tucatinib treatment.
Sources for this answer
- TUKYSA 50 mg film-coated tabletPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked